Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
2(33%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph early_phase_1
1
17%
Ph phase_1
1
17%
Ph not_applicable
1
17%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
Recruiting2
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
66.7%
Most Advanced
Phase 1

Trials by Phase

Early Phase 11 (33.3%)
Phase 11 (33.3%)
N/A1 (33.3%)

Trials by Status

terminated117%
unknown117%
completed233%
recruiting233%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
PROCEDURE
Total Trials
6